Navigation Links
HeartWare Schedules Third Quarter Conference Call and Webcast
Date:10/21/2011

FRAMINGHAM, Mass. and SYDNEY, Oct. 21, 2011 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR, ASX:HIN) has scheduled a conference call to discuss its financial results for the three and nine months ended September 30, 2011, at 8:00 am U.S. Eastern Daylight Time on Friday, October 28, 2011 (being 11:00 pm Australian Eastern Daylight Time, Friday, October 28, 2011). The Company plans to release the financial results prior to the conference call.

The conference call with management will discuss the Company's financial results, highlights from the quarter and business outlook.  The call may be accessed by dialing 1-877-941-2068 five minutes prior to the scheduled start time and referencing "HeartWare."  For callers outside the U.S., please dial +1-480-629-9712.

A live webcast of the call will also be available at the Company's website (www.heartware.com) by selecting "HeartWare Third Quarter 2011 Conference Call" under the section titled "Corporate Presentations" on the Home Page.  A replay of the conference call will be available through the above weblink immediately following completion of the call.

A copy of the news release announcing results and related information will be available on the Company's web site, www.heartware.com.

About HeartWare International

HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure.  The HeartWare® Ventricular Assist System features the HVAD® Pump, a small full-output circulatory support device (up to 10L/min flow) designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices.  HeartWare has received CE Marking for the HeartWare System in the European Union and TGA approval in Australia.  The device is currently the subject of United States clinical trials for two indications: bridge-to-transplant under a continued access protocol and destination therapy.  For additional information, please visit www.heartware.com.

HeartWare International, Inc. is a member of the Russell 2000® and its securities are publicly traded on The NASDAQ Stock Market and the Australian Securities Exchange.

For further information:

Christopher Taylor
HeartWare International, Inc.
Email: ctaylor@heartwareinc.com
Phone: +1 508 739 0864


'/>"/>
SOURCE HeartWare International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. U.S. Federal Trade Commission to Challenge Thoratecs Proposed Acquisition of HeartWare International
2. HeartWare International, Inc. Temporary Suspension of Trading
3. HeartWare to Present at the 22nd Annual Piper Jaffray Health Care Conference
4. HeartWare to Report 2010 Fourth Quarter and Year-End Financial Results
5. HeartWare Completes GLP Studies of Next Generation MVAD® Pump; Data Presented Today at ISRBP Congress
6. HeartWare to Present at the UBS Global Life Sciences Conference
7. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
8. Cyprus and Ireland Add Wyeths 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to Their National Immunisation Schedules
9. Cepheid Schedules Fiscal 2008 Third Quarter Financial Results Announcement and Webcast
10. 3SBio Inc. Schedules 2008 Third Quarter Earnings Release on Monday, November 10, 2008
11. Bunge Limited Schedules Third Quarter 2008 Earnings Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/10/2017)... ... August 09, 2017 , ... ... in the clinic is here. The team at Capricor Therapeutics, Inc. utilized a ... for clinical studies. , Dr. Travis Antes, head of analytical development at ...
(Date:8/10/2017)... SAN DIEGO, California, USA (PRWEB) , ... August ... ... and photonics, has partnered with four international biomedical optics laboratories — the Wellman ... Massachusetts General Hospital, Medical Laser Center Lübeck and the Beckman Laser Institute at ...
(Date:8/10/2017)... Coral Springs, FL (PRWEB) , ... August 10, ... ... today announced that the stock market news outlet had initiated coverage on Next ... the rapidly growing and underserved consumer markets geared toward those that cannot engage ...
(Date:8/8/2017)... ... August 08, 2017 , ... HumanZyme Inc., a leading ... today announced the launch of HumanKine® Interferon beta (IFN beta) expressed ... interferons that activate Th1-type innate immune responses against viral and bacterial infection, and have ...
Breaking Biology Technology:
(Date:3/29/2017)... , March 29, 2017  higi, the health ... in North America , today announced ... and the acquisition of EveryMove. The new investment and ... set of tools to transform population health activities through ... lifestyle data. higi collects and secures data ...
(Date:3/24/2017)... -- The Controller General of Immigration from Maldives Mr. ... have received the prestigious international IAIR Award for the most innovative high ... ... Maldives Immigration Controller ... (small picture on the right) have received the IAIR award for the ...
(Date:3/23/2017)... 2017 Research and Markets has announced the ... Trends - Industry Forecast to 2025" report to their offering. ... The Global ... of around 8.8% over the next decade to reach approximately $14.21 ... market estimates and forecasts for all the given segments on global ...
Breaking Biology News(10 mins):